MW1389A1 - Heterocyclic compounds - Google Patents

Heterocyclic compounds

Info

Publication number
MW1389A1
MW1389A1 MW13/89A MW1389A MW1389A1 MW 1389 A1 MW1389 A1 MW 1389A1 MW 13/89 A MW13/89 A MW 13/89A MW 1389 A MW1389 A MW 1389A MW 1389 A1 MW1389 A1 MW 1389A1
Authority
MW
MALAWI
Prior art keywords
inhibitors
concerns novel
heterocyclic compounds
heterocyclic
nitromethane derivatives
Prior art date
Application number
MW13/89A
Other languages
English (en)
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of MW1389A1 publication Critical patent/MW1389A1/xx

Links

Classifications

    • GPHYSICS
    • G10MUSICAL INSTRUMENTS; ACOUSTICS
    • G10BORGANS, HARMONIUMS OR SIMILAR WIND MUSICAL INSTRUMENTS WITH ASSOCIATED BLOWING APPARATUS
    • G10B3/00Details or accessories
    • G10B3/12Keys or keyboards; Manuals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/64Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91Dibenzofurans; Hydrogenated dibenzofurans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/76Dibenzothiophenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Physics & Mathematics (AREA)
  • Multimedia (AREA)
  • Acoustics & Sound (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Air Bags (AREA)
  • Detergent Compositions (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Furan Compounds (AREA)
MW13/89A 1988-04-29 1989-03-30 Heterocyclic compounds MW1389A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888810203A GB8810203D0 (en) 1988-04-29 1988-04-29 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
MW1389A1 true MW1389A1 (en) 1989-12-13

Family

ID=10636116

Family Applications (1)

Application Number Title Priority Date Filing Date
MW13/89A MW1389A1 (en) 1988-04-29 1989-03-30 Heterocyclic compounds

Country Status (20)

Country Link
US (1) US5102905A (xx)
EP (1) EP0340010B1 (xx)
JP (1) JPH01316355A (xx)
KR (1) KR900016937A (xx)
CN (1) CN1037339A (xx)
AT (1) ATE110378T1 (xx)
AU (1) AU623128B2 (xx)
DD (1) DD283817A5 (xx)
DE (1) DE68917634D1 (xx)
DK (1) DK200889A (xx)
FI (1) FI892038A (xx)
GB (2) GB8810203D0 (xx)
HU (1) HUT49868A (xx)
MW (1) MW1389A1 (xx)
NO (1) NO891707L (xx)
NZ (1) NZ228915A (xx)
PT (1) PT90395B (xx)
ZA (1) ZA892597B (xx)
ZM (1) ZM1889A1 (xx)
ZW (1) ZW5989A1 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL93178A0 (en) * 1989-02-03 1990-11-05 Ici Plc Benzheterocyclyl sulphones
GB9016978D0 (en) * 1990-08-02 1990-09-19 Ici Plc Acetamide derivatives
US5250570A (en) * 1990-08-02 1993-10-05 Imperial Chemical Industries Plc Amidobenzene derivatives, compositions and use
NZ254550A (en) * 1992-09-28 1997-08-22 Pfizer Use of nitrogen-substituted pyrimidines to prepare medicaments useful for treatment or prevention of diabetic complications
JPH10503501A (ja) * 1994-08-03 1998-03-31 アスタ メディカ アクチエンゲゼルシャフト 抗喘息、抗アレルギー、抗炎症及び免疫修飾作用を有するインドール、インダゾール、ピリドピロール及びピリドピラゾール誘導体
DK0832065T3 (da) * 1995-06-06 2001-11-19 Pfizer Substituerede N-(indol-2-carbonyl)glycinamider og derivater som glycogenphosphorylaseinhibitorer
US7597884B2 (en) 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
CN110551015B (zh) * 2018-05-31 2022-06-21 株式会社Lg化学 化合物及利用其的有机发光元件
KR102229001B1 (ko) * 2018-05-31 2021-03-17 주식회사 엘지화학 신규한 화합물 및 이를 이용한 유기 발광 소자

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053633A (en) * 1976-06-24 1977-10-11 The Dow Chemical Company Aryl dibromonitromethyl sulfones
US4670470A (en) * 1979-08-15 1987-06-02 Merck & Co., Inc. Allylsulfoxide enzyme inhibitors
US4309554A (en) * 1980-04-28 1982-01-05 The Dow Chemical Company 3-(2-Thiophenesulfonyl)-2-halopropanenitriles
JPS5740478A (en) * 1980-08-22 1982-03-06 Ono Pharmaceut Co Ltd Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative
DD216237A1 (de) * 1983-06-23 1984-12-05 Univ Halle Wittenberg Verfahren zur herstellung von substituierten 4-phenyl-thiophenen
EP0252640B1 (en) * 1986-06-30 1991-03-06 Merck & Co. Inc. Alkanesulfonamides as antiglaucoma agents
GB8718619D0 (en) * 1987-08-06 1987-09-09 Ici Plc Pharmaceutical compositions

Also Published As

Publication number Publication date
AU3308089A (en) 1989-11-02
NO891707L (no) 1989-10-30
NO891707D0 (no) 1989-04-25
ATE110378T1 (de) 1994-09-15
ZW5989A1 (en) 1990-01-03
PT90395A (pt) 1989-11-10
HUT49868A (en) 1989-11-28
ZA892597B (en) 1989-12-27
DK200889D0 (da) 1989-04-25
GB8906822D0 (en) 1989-05-10
AU623128B2 (en) 1992-05-07
EP0340010A3 (en) 1991-05-15
US5102905A (en) 1992-04-07
FI892038A0 (fi) 1989-04-28
JPH01316355A (ja) 1989-12-21
ZM1889A1 (en) 1990-01-26
NZ228915A (en) 1991-12-23
FI892038A (fi) 1989-10-30
CN1037339A (zh) 1989-11-22
DK200889A (da) 1989-10-30
EP0340010A2 (en) 1989-11-02
EP0340010B1 (en) 1994-08-24
GB8810203D0 (en) 1988-06-02
KR900016937A (ko) 1990-11-14
DE68917634D1 (de) 1994-09-29
DD283817A5 (de) 1990-10-24
PT90395B (pt) 1995-03-31

Similar Documents

Publication Publication Date Title
ES2056190T3 (es) Derivados de 4(4-fenil-1-piperazinil)fenoles, inhibidores de 5-lipoxigenasa.
AU643489B2 (en) Antibacterial agents - II
DK0412404T3 (da) Thiazolderivater, fremgangsmåder til fremstilling deraf og farmaceutiske præparater omfattende derivaterne
GR3003378T3 (en) Process for the synthesis of 3-thio-4-quinolone derivatives and intermediate compounds for use therein, and their use as medicaments
EP0614913A3 (en) Dynorphin derivatives.
ZM1889A1 (en) Heterocyclic compounds
ATE133161T1 (de) (p-carbonylaminophenyl)- sulphonylnitromethanderivate
IL77051A0 (en) Novel crystalline form of benzothiazine dioxide salt and pharmaceutical compositions containing it
GB2227745B (en) Phenylsulphone derivatives
DE3464915D1 (en) (5-(2-aminomethyl-imidazol-1-yl)-1,3-dialkyl-1h-pyrazol-4-yl)(aryl)methanones and processes for their production
AU2639388A (en) 2-cyano-2-aryl-1-(azole-1-yl)- ethane derivatives
AU553765B2 (en) Biologically active heterocyclic hydroximidates and thiolhydroximidates and carbamate ester derivatives thereof
AU1656588A (en) New alkanesulfonanilide derivatives, processes for preparation thereof and pharmaceutical composition comprising the same